KalVista Pharmaceuticals
KALV
#6267
Rank
A$1.27 B
Marketcap
A$25.20
Share price
-0.24%
Change (1 day)
70.24%
Change (1 year)

KalVista Pharmaceuticals (KALV) - Total debt

Total debt on the balance sheet as of September 2025 : A$0.22 Billion

According to KalVista Pharmaceuticals's latest financial reports the company's total debt is A$0.22 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

KalVista Pharmaceuticals - Total debt on balance sheet (from 2013 to 2025)

Total debt by year

Year Total debt Change
2025-04-30A$9.83 M-12.93%
2024-04-30A$11.29 M-9.27%
2023-04-30A$12.44 M7.45%
2022-04-30A$11.58 M51.23%
2021-04-30A$7.66 M202.53%
2020-04-30A$2.53 M
2019-04-30N/A-100%
2018-04-30A$0.37 M
2015-12-31A$6.32 M-21.14%
2014-12-31A$8.02 M133.64%
2013-12-31A$3.43 M32.91%
2012-12-31A$2.58 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ORIC Pharmaceuticals
ORIC
A$4.94 M-97.79%๐Ÿ‡บ๐Ÿ‡ธ USA